UK life sciences

Patients

Union Jack on pill, one of many scattered on aqua surface

Rare diseases, real opportunity: Why the UK’s next challenge...

The UK has the science, the talent, and the investment. The next step is ensuring that innovation translates into timely patient impact.

R&D

The future of Oxford: Science, technology, and collaboration

In conversation with Professor Lady Sue Black and Simon Ruck about Oxford North, from opening to today.

R&D

The UK life sciences sector at a crossroads: Bold decisions ...

We all want the same thing: for the UK to succeed, for our workforces to thrive, and for patients and the NHS to benefit.

Market Access

Health, growth & renewal: ABPI 2026 looks to UK’s future

The Association of the British Pharmaceutical Industry (ABPI)'s flagship annual conference took place on Thursday, 23rd April.

News

UK Knowledge Quarter welcomes Boehringer Ingelheim AI accele...

Boehringer Ingelheim has announced expansion of its global Computational Innovation footprint with a new centre dedicated to AI & ML in the UK.

R&D

Why the government’s latest funding push is critical to the ...

Many of the UK’s most promising life sciences innovations continue to face persistent funding challenges, made worse by an increasingly volatile globa